Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hot Flashes × Venlafaxine Hydrochloride × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Conditions

Hot Flashes 1 Depression 1 Breast Neoplasms 1

Interventions

Venlafaxine Hydrochloride 1 Tamoxifen 1 Sertraline 1 Genetic Testing 1 Gabapentin 1 Escitalopram 1 Citalopram 1 Chromatography, High Pressure Liquid 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Breast Neoplasms, Depression, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡